期刊文献+

醛固酮调控大鼠心肌钙调神经磷酸酶抑制因子的机制

The mechanism of aldosterone regulated rat cardiac calcineurin-inhibitor
暂未订购
导出
摘要 目的:通过皮下注射醛固酮(A ld),诱导大鼠心肌肥厚反应发生,采用蛋白印记杂交的方法,观察心肌组织钙调神经磷酸酶(CaN)抑制因子(Cain)表达的变化。方法:健康雄性W istar大鼠,随机分为3组(n=7),①正常对照组;②心肌肥厚组:皮下注射A ld 18μg.d-1,连续14 d;③螺内酯组:皮下注射A ld 18μg.d-1,同时给予螺内酯20mg.kg-1.d-1灌胃,亦连续14 d。采用大鼠尾动脉法测量平均动脉压,称重后抽血处死,分别计算左心室质量(LVW)及全心质量(HW)与体质量(BW)的比值。通过放免方法测定血浆A ld含量,运用蛋白印记杂交的方法,测定Cain表达的变化。结果:心肌肥厚组与正常对照组比较,BP显著升高,LVW/BW及HW/BW比值显著增加,血浆A ld增加,CaN活性增加,Cain的表达显著增加;而螺内酯组与心肌肥厚组比较,LVW/BW及HW/BW比值下降,血浆A ld增加,CaN活性减低,Cain的表达显著减少,而BP无明显变化。结论:外源性醛固酮可通过CaN依赖的信号转导通路诱导心肌肥厚反应的发生。同时,机体内源性Cain的表达的变化,受到CaN信号转导系统调控。 AIM: To investigate the changes of myocardial calcineurin inhibitor ( Cain ) level in external aldosterone-induced cardiac hypertrophic rats. METHODS: Male Wistar rats were randomly divided into three groups: The control group, the Ald group treated with Ald( 18μg·d^-1×14d), and spironolactone group treated with Aid ( 18μg·d^-1×14d) and the spironolactone (20mg·kg^-1·d^-1×14 d). Ang Ⅱ and Aid levels in plasma were determined by radioimmunoassay. The expression of myocardial Cain levels were determined by Western Blot. RESULTS : The Aid level , the expression of Cain and the activity of calcineurin in myocardium, all increased in the Ald group compared with the control group. And Aid level markedly increased in the spironolactone group compared with the Aid group; meanwhile, the expression of myocardial Cain and the activity of calcineurin decreased significantly. CONCLUSION: External Aid induces cardiac hypertrophy through a calcineurin-depedent signal pathway. The expression of internal Cain may be controlled by the activity of calcineurin.
出处 《心脏杂志》 CAS 2005年第4期317-319,共3页 Chinese Heart Journal
基金 "十五"军队医药卫生科研基金重点课题资助(No.02Z0010)
关键词 醛固酮 钙调神经磷酸酶抑制因子 aldosterone calcineurin-inhibitor
  • 相关文献

参考文献7

  • 1Zou Y, Hiroi Y, Uozumi H, et al. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy[J]. Circulation, 2001,104: 97-101.
  • 2Rick B, Vega R, Beverly A, et al. Dual roles of modulatory calcineruin-interacting protein 1 in cardiac hypertrophy[J]. Proc Natl Acad Sci USA, 2003,100:669 -674.
  • 3Taigen T, De Windt L, Lim HW, et al. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy [ J ].Proc Natl Acad Sci USA, 2000,97 : 1196 - 1201.
  • 4符民桂,唐朝枢.钙调神经磷酸酶活性测定[J].中国动脉硬化杂志,2000,8(1):82-83. 被引量:26
  • 5De Windt L, Lim HW, Bueno OF, et al. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo[ J]. Proc Natl Acad Sci USA, 2001,98:3322- 3327.
  • 6Bueno OF, Wilkings BJ, Tymitz KM, et al. Impaired cardiac hypertrophic response in calcineurin Aβ-deficient mice [J]. Proc Natl Acad Sci USA, 2002,99:4586-4591.
  • 7Sakata Y, Masuyama T, Yamamoto K, et al. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats [ J ]. Circulation, 2000, 102 : 2259 -2275.

二级参考文献3

  • 1Molkentin J D,Cell,1998年,93卷,215页
  • 2Klee C B,J Biol Chem,1998年,273卷,13367页
  • 3Pallen C J,J Biol Chem,1983年,258卷,8550页

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部